Diabetes Diminishes Phosphatidic Acid in the Retina: A Putative Mediator for Reduced mTOR Signaling and Increased Neuronal Cell Death
Author(s) -
Todd E. Fox,
Megan M. Young,
Michelle M. Pedersen,
Xianlin Han,
Thomas W. Gardner,
Mark Kester
Publication year - 2012
Publication title -
investigative ophthalmology and visual science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.935
H-Index - 218
eISSN - 1552-5783
pISSN - 0146-0404
DOI - 10.1167/iovs.11-7626
Subject(s) - pi3k/akt/mtor pathway , p70 s6 kinase 1 , protein kinase b , biology , rptor , microbiology and biotechnology , signal transduction , insulin receptor , phosphatidic acid , insulin , mtorc1 , endocrinology , medicine , insulin resistance , biochemistry , phospholipid , membrane
We demonstrated previously that pro-survival insulin receptor, PI3K-Akt, and p70 S6K signaling is diminished in models of diabetic retinopathy. As mammalian target of rapamycin (mTOR), an upstream activator of p70 S6Kinase is, in part, regulated by lipid-derived second messengers, such as phosphatidic acid (PA), we sought to determine if diminished mTOR/p70 S6Kinase signaling in diabetic retinas may reflect diminished PA levels.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom